A Real-World Analysis of Relapse Rate and Efficacy of a Restricted Monthly Dose of Omalizumab in Recalcitrant Chronic Spontaneous Urticaria in India

Shranjeno v:
Bibliografske podrobnosti
izdano v:Indian Dermatol Online J
Main Authors: Sardana, Kabir, Dixit, Niharika, Arora, Pooja
Format: Artigo
Jezik:Inglês
Izdano: Wolters Kluwer - Medknow 2020
Teme:
Concise Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678515/
https://ncbi.nlm.nih.gov/pubmed/33235861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/idoj.IDOJ_499_19
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki